Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
September 6, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesTherapeutic system for administering clonidine transdermally Method and therapeutic system for administering scopolamine transdermally Transdermal release system for pharmaceutical preparation Pressure sensitive adhesive film for medical use Transdermal delivery of highly ionized fat insoluble drugs Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols Transdermal delivery of drugs from an aqueous reservoir Transdermal drug delivery using a dual permeation enhancer and method of performing the same Transdermal delivery of (+) (2S,3S)-3-acetoxy-8-chloro-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-met hoxyphenyl)-1,5-benzothiazepin-4-(5H)-one Misuse-resistive transdermal opioid dosage form InventorsApplicationNo. 706624 filed on 09/06/1996US Classes:424/449, Transdermal or percutaneous424/447, Bandages with incorporated medicaments424/448Pressure sensitive adhesive meansExaminersPrimary: Page, Thurman K.Assistant: Shelborne, Kathryne E. Attorney, Agent or FirmInternational ClassA61L 015/16AbstractA method of transdermally or transmucosally delivering a hydrophilic salt form of a drug with a water-based pressure sensitive hydrophobic adhesive matrix patch optionally containing a permeation enhancer is disclosed. A matrix patch comprising a water-based pressure sensitive hydrophobic adhesive, a hydrophilic salt form of a drug, and optionally a permeation enhancer for transdermal or transmucosal delivery of the hydrophilic salt form of the drug is also disclosed.Other References
| |
